James M Brewer Selected Research

Parasitic Diseases (Parasitic Disease)

2/2014

Using lymph node transplantation as an approach to image cellular interactions between the skin and draining lymph nodes during parasitic infections.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James M Brewer Research Topics

Disease

11	Infections 01/2020 - 02/2003
10	Rheumatoid Arthritis 01/2022 - 10/2005
9	Arthritis (Polyarthritis) 10/2021 - 12/2002
7	Inflammation (Inflammations) 01/2022 - 01/2007
4	Malaria 01/2020 - 01/2006
4	Experimental Arthritis 08/2011 - 12/2002
3	Atherosclerosis 06/2015 - 11/2012
2	Joint Diseases (Joint Disease) 01/2018 - 08/2010
2	Autoimmune Diseases (Autoimmune Disease) 04/2010 - 10/2005
1	Neoplasms (Cancer) 01/2020
1	Necrosis 01/2018
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2017
1	Hypersensitivity (Allergy) 08/2014
1	Asthma (Bronchial Asthma) 08/2014
1	Parasitic Diseases (Parasitic Disease) 02/2014
1	Parasitemia 01/2013
1	Fibrosis (Cirrhosis) 09/2012
1	Chronic Disease (Chronic Diseases) 08/2011
1	Osteoarthritis 06/2011
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2011
1	Virus Diseases (Viral Diseases) 04/2010
1	Coinfection 01/2006
1	Hyperplasia 10/2005

Drug/Important Bio-Agent (IBA)

6	AntigensIBA 01/2021 - 07/2004
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2009
3	Collagen Type II (Type II Collagen)IBA 03/2016 - 01/2009
2	AutoantibodiesIBA 10/2021 - 08/2010
2	AntibodiesIBA 01/2020 - 08/2011
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 02/2013
2	CollagenIBA 03/2016 - 12/2002
2	Abatacept (Orencia)FDA Link 03/2016 - 08/2010
2	CytokinesIBA 09/2012 - 01/2007
2	OvalbuminIBA 08/2011 - 07/2004
2	VaccinesIBA 07/2010 - 01/2006
2	Liposomes (Liposome)IBA 07/2010 - 01/2007
2	Heterophile AntigensIBA 10/2007 - 01/2006
2	hemozoinIBA 10/2007 - 01/2006
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Junctional Adhesion Molecule AIBA 01/2020
1	Interferon-gamma (Interferon, gamma)IBA 01/2018
1	Antimalarials (Antimalarial Agents)IBA 01/2018
1	Antigen Receptors (Antigen Receptor)IBA 01/2018
1	artemisinin (artemisinine)IBA 01/2018
1	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 01/2017
1	Caspase 3 (Caspase-3)IBA 01/2017
1	Freund's AdjuvantIBA 03/2016
1	Lymphotoxin-alpha (Lymphotoxin)IBA 06/2015
1	Apolipoproteins E (ApoE)IBA 06/2015
1	fostamatinibIBA 01/2015
1	Interleukin-13IBA 08/2014
1	DiminazeneIBA 01/2013
1	Pharmaceutical PreparationsIBA 01/2013
1	ApolipoproteinsIBA 11/2012
1	ChemokinesIBA 09/2012
1	aluminum sulfate (alum)IBA 03/2012
1	EpitopesIBA 08/2011
1	ChromiumIBA 06/2011
1	AlloysIBA 06/2011
1	CobaltIBA 06/2011
1	MetalsIBA 06/2011
1	salicylhydroxamic acid (SHAM)IBA 05/2011
1	Green Fluorescent ProteinsIBA 05/2011
1	DNA (Deoxyribonucleic Acid)IBA 07/2010
1	Interferon Type IIBA 04/2010
1	Biological ProductsIBA 01/2009
1	Rheumatoid FactorIBA 01/2009
1	Peptides (Polypeptides)IBA 01/2009
1	LactoferrinIBA 01/2007
1	Interleukin-18 (Interleukin 18)IBA 06/2004
1	Immunoglobulin E (IgE)IBA 02/2003
1	Tumor Necrosis Factor InhibitorsIBA 12/2002

Therapy/Procedure

4	Therapeutics 01/2018 - 10/2005
1	Immunotherapy 10/2021
1	Drug Therapy (Chemotherapy) 01/2018
1	Transplantation 02/2014
1	Aftercare (After-Treatment) 01/2013
1	Lasers (Laser) 05/2011
1	Electrocoagulation (Electrocautery) 05/2011